Novogen wins FDA OK for final phase of cancer trial
(R


Reuters - Novogen Ltd. on Friday said it won
clearance from the U.S. Food and Drug Administration to go
ahead with the final phase of human clinical testing on its
lead anti-cancer drug, phenoxodiol.